Table 3.
Accession Numbera | Protein Nameb | Coverage | Number of Identified Peptides | Developmental Stagec |
---|---|---|---|---|
AAM47176.1 | surface glycoprotein GP90 | 40% | 82 | MT |
EAN87246.1 | trans-sialidase, putative (GP90) | 23% | 14 | MT |
ABR19835.1 | stage-specific surface protein GP82 | 22% | 31 | MT |
BAF74647.1 | glycoprotein 82 kDa | 18% | 20 | MT |
BAF74641.1 | glycoprotein 82 kDa | 14% | 18 | MT |
EAN81650.1 | trans-sialidase, putative (GP90) | 13% | 24 | MT |
EAN91385.1 | trans-sialidase, putative (GP90) | 10% | 10 | MT |
EAN99311.1 | trans-sialidase, putative (GP90) | 10% | 3 | MT |
ABR19836.1 | stage-specific surface protein GP82 | 9% | 2 | MT |
EAN95004.1 | trans-sialidase, putative (GP90) | 9% | 20 | MT |
AAP22091.1 | GP63 group I member b protein | 9% | 3 | MT |
EAN98599.1 | trans-sialidase, putative (ASP-2) | 9% | 2 | MT |
EAN82035.1 | procyclic-form surface glycoprotein, putative | 9% | 3 | E |
EAN95001.1 | trans-sialidase, putative (GP90) | 8% | 14 | MT |
AAA18827.1 | surface glycoprotein (GP85) | 8% | 6 | MT |
EAN82322.1 | trans-sialidase, putative (Tc-85/16) | 8% | 15 | MT |
EAN93322.1 | trans-sialidase, putative (GP85-TSA-E2) | 8% | 5 | MT |
EAN95642.1 | trans-sialidase, putative (GP85-TSA-E3) | 8% | 16 | MT |
EAN96370.1 | trans-sialidase, putative (Tc-85/16) | 8% | 16 | MT |
EAN98005.1 | procyclic-form surface glycoprotein, putative | 7% | 2 | MT, E |
EAN93266.1 | trans-sialidase, putative (Tc85−11) | 6% | 14 | MT |
AAB18265.1 | surface protein-1, ASP-1 | 6% | 6 | MT |
EAN82837.1 | trans-sialidase, putative (GP82) | 6% | 4 | MT |
AAD10620.1 | surface glycoprotein, GP85 | 6% | 5 | MT |
AAM47178.1 | surface glycoprotein GP90 | 6% | 1 | MT |
EAN88221.1 | trans-sialidase, putative (GP90) | 6% | 8 | MT |
EAN98004.1 | procyclic-form surface glycoprotein, putative | 5% | 1 | E |
EAN93978.1 | mucin TcMUCII, putative | 5% | 1 | MT |
EAN88154.1 | trans-sialidase, putative (GP82) | 5% | 6 | MT |
ABQ53588.1 | surface protein-2, ASP-2 | 5% | 3 | MT |
EAN82390.1 | trans-sialidase, putative (ASP-2) | 5% | 5 | MT |
EAN90192.1 | trans-sialidase, putative (GP90) | 5% | 10 | MT |
BAF74652.1 | glycoprotein 82 kDa | 5% | 3 | MT |
A48458 | gp85/sialidase homolog | 4% | 1 | MT |
EAN84247.1 | extracellular receptor, putative | 4% | 1 | E |
EAN86738.1 | trans-sialidase, putative (GP85-SA85−1.2) | 4% | 4 | MT |
AAC47720.1 | amastigote surface protein-2, ASP-2 | 3% | 2 | MT |
AAD13347.1 | surface glycoprotein Tc85−11 | 3% | 1 | E |
EAN91734.1 | trans-sialidase, putative (GP90) | 3% | 1 | MT |
EAN93068.1 | trans-sialidase, putative (GP85-TSA-1) | 3% | 3 | MT |
EAN98006.1 | procyclic-form surface glycoprotein, putative | 2% | 1 | MT |
EAN82034.1 | procyclic-form surface glycoprotein, putative | 2% | 1 | E |
ABO28970.1 | trans-sialidase-like protein (GP82) | 2% | 2 | MT |
EAN85322.1 | trans-sialidase, putative (ASP-2) | 2% | 1 | MT |
GenBank accession number.
Sequences annotated as putative trans-sialidases (TS) in the T. cruzi genome-sequencing project were assigned to the families (indicated in the parentheses) of TS superfamily according to Azuaje.29
MT, metacyclic trypomastigote; E, epimastigote.